| JYHB2101244 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-07-09 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHB2200187 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-08 | | Novartis Pharma Schweiz AG | | | view |
| CYHS2501775 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2025-05-15 | | Jiangsu Huayang Pharmaceutical Co Ltd;Jiangsu Huaxin Pharmaceutical Co Ltd | | | view |
| JYHB2101243 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-07-09 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHB2200188 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2022-04-08 | | Novartis Pharma Schweiz AG | | | view |
| CYHB2401853 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Supplementary Application | 2024-11-09 | | Kunshan Rotam Reddy Pharmaceutical Co Ltd;Shandong Langnuo Pharmaceutical Co Ltd | | | view |
| JYHZ2100621 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | License Renew | 2021-09-16 | | Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHZ2100622 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | License Renew | 2021-09-16 | | Beijing Novartis Pharma Co Ltd;Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| JYHB2400518 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2024-10-01 | | Novartis Pharma Schweiz AG | | | view |
| JYHB2101056 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-23 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| CYHS2200235 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2022-01-29 | | CSPC OUYI Pharmaceutical Co Ltd | | | view |
| CYHB2302363 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Supplementary Application | 2023-10-25 | | Shanghai Acebright Pharmaceuticals Co Ltd;Jiangsu Yahong Meditech Co Ltd | | | view |
| JYHB2101057 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs | Supplementary Application | 2021-04-23 | | Glaxo Operations UK Ltd;Novartis Pharma Schweiz AG | | | view |
| CYHS2302309 | 培唑帕尼片 | pazopanib | Tablet | Chemical Drugs(4) | Generic Drug | 2023-08-30 | | Shandong Langnuo Pharmaceutical Co Ltd | | | view |
| JXHL0700343 | GW786034B片 | pazopanib | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2007-11-06 | SmithKline Beecham Corporation, doing business as GlaxoSmithKline | Smithkline Beecham Corporation | Certificate Issued | 2009-08-26 | view |
| JXHL0700342 | GW786034B片 | pazopanib | Tablet | Chemical Drugs(1.1) | Import Drug Application | 2007-11-06 | SmithKline Beecham Corporation, doing business as GlaxoSmithKline | Smithkline Beecham Corporation | Certificate Issued | 2009-08-26 | view |
| JXHL0800461 | Pazopanib(GW786034B)Tablets | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2009-01-15 | SmithKline Beecham Corporation | Smithkline Beecham Corporation | Certificate Issued | 2009-09-22 | view |
| JXHL0800462 | Pazopanib (GW786034B) Tablets | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2009-01-04 | SmithKline Beecham Corporation | Smithkline Beecham Corporation | Certificate Issued | 2009-09-22 | view |
| JXHL0900109 | Pazopanib(GW786034B)Tablets | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2009-04-09 | SmithKline Beecham Corporation | Smithkline Beecham Corporation | Certificate Issued | 2009-12-24 | view |
| JXHL0900110 | Pazopanib(GW786034B)Tablets | pazopanib | Tablet | Chemical Drugs | Import Drug Application | 2009-04-08 | SmithKline Beecham Corporation | Smithkline Beecham Corporation | Certificate Issued | 2009-12-24 | view |
